You are here

Article metrics

Article menu

Download PDFPDF

Late-breaking abstracts
Clinical trials in-progress
802 Ramucirumab plus atezolizumab in patients with stage IV non-small cell lung cancer previously treated with immune checkpoint blockade

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020137040
Dec 20202007
Jan 20211401
Feb 20213603
Mar 20213407
Apr 20211403
May 2021702
Jun 2021005
Jul 2021004
Aug 2021003
Sep 2021004
Oct 202114028
Nov 202124015
Dec 20212201
Jan 20221603
Feb 20221402
Mar 20223402
Apr 20223203
May 20221402
Jun 20221403
Jul 20223204
Aug 202242018
Sep 20222404
Oct 20221602
Nov 202212017
Dec 20222003
Jan 20232003
Feb 20234400
Mar 20231401
Apr 20231602
May 2023200
Jun 2023203
Jul 20231002
Aug 20231203
Sep 20231201
Oct 2023602
Nov 20231401
Dec 20231600
Jan 2024800
Feb 20241000
Mar 20241400
Apr 20241206
May 20241801
Jun 20242405
Jul 20241002
Aug 20241400
Sep 20241402
Oct 20241203
Nov 20242204
Dec 2024603
Jan 2025804
Feb 2025203
Mar 2025003
Apr 2025003
May 2025007
Jun 2025006
Total9340256